Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Post by NorthSunon Jul 28, 2020 3:39pm
224 Views
Post# 31332988

The Aphria Stock Surge And What It Means For Investors

The Aphria Stock Surge And What It Means For InvestorsBackgrounder:

Aphria stocks have just surged upwards 12.3 percent yesterday and the forecast is promising for the next four years. A U.S. based global financial services firm– Cantor Fitzgerald– reported prosperous earnings for Aprhia (NASDAQ:APHA), especially by the end of 2024. Cantor Fitzgerald– an innovative investment bank founded in 1945– provides advisory services such as mergers, acquisitions, and strategic partnerships among other services. The company’s financial analyst Pablo Zuanic recently named Aphria his top pick for Canadian Cannabis stocks. Zuanic increased his price forecast for Aphria from $7.86 to $8.23. Based on Aphria’s last closing stock price– $5.74– the new target price is a promising target price representing potential gain “for investors of more than 40 per cent.” Zuanic also predicts that Aphria could win over other U.S. and Canadian cannabis stocks in the next four years as Canadian cannabis markets could potentially grow to $31 billion and $6.2 billion by 2024.

RELATED POSTS

3 Things to Look For When Aphria Releases Q4 and Full Year…
Jul 27, 2020

https://thedalesreport.com/cannabis/the-aphria-stock-surge-and-what-it-means-for-investors/?fbclid=IwAR0MUnZek6xWPEFS9NSoOn4tN_5ro4kicoRl-JK5qsthzxZHGpFOZqDr6Sk


Bullboard Posts